News from all angles
(MedPage Today) -- Multiple sclerosis (MS) patients exposed to a GLP-1 receptor agonist had lower rates of relapse activity and steroid use, reduced incidence of optic neuritis, and fewer demyelinati…
Redirecting to MedPage Today in 3 seconds...
Share this story with your network